The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global glycomics or glycobiology market is poised for remarkable growth, projected to surge from $1.38 billion in 2022 to $1.60 billion in 2023, with an impressive compound annual growth rate (CAGR) of 15.7%. Looking ahead, the market is expected to reach $2.82 billion in 2027, sustaining a robust CAGR of 15.2%. Let’s delve into the factors fueling this growth and the key players steering the course of the glycomics landscape.

**1. Demand for Medicines in Chronic Disease Treatment: A Driving Force

• The glycomics or glycobiology market is propelled by the escalating demand for medicines to treat severe chronic diseases.
• Chronic diseases, characterized by long-term health issues, are a key focus for glycomics studies, which explore changes in glycosylation and its functions.
• Notably, cancer, a chronic disease, is on the rise, with an anticipated 22.5 million cancer survivors by 2032, emphasizing the need for innovative drug development. Keytruda, a cancer immunotherapy drug, witnessed substantial revenue growth, reaching $14.38 billion in 2020.

**2. Market Leaders: Pioneering Glycomics Innovations

• Major players shaping the glycomics or glycobiology market include Water Corporation, Agilent Technologies, Bruker Corporation, Merck KgaA, and others.
• These industry giants contribute to the market’s diversity, offering products ranging from enzymes and kits to instruments and carbohydrates, catering to the varied needs of drug discovery, disease diagnostics, and other applications.

**3. Research and Development Investments: A Trend in Focus

• Research and development activities are emerging as a key trend in the glycomics or glycobiology market.
• Noteworthy investments include Griffith University’s launch of the ACRF International Centre for Cancer Glycomics in August 2022, backed by a $2.6 million ACRF grant.
• This unique facility aims to unravel the cancer glyco-code, fostering a better understanding that can lead to novel discoveries and improved clinical outcomes for cancer patients.

**4. Segmentation Insights: Navigating the Glycomics Landscape

• The glycomics or glycobiology market is segmented by product, encompassing enzymes, kits, reagents and chemicals, instruments, and carbohydrates.
• Applications span drug discovery and development, disease diagnostics, and other specialized areas, catering to the diverse needs within the healthcare sector.
• End-users include academic research institutes, pharmaceutical and biotechnology companies, and clinical laboratories, reflecting the collaborative efforts across different domains.

**5. Regional Dynamics: North America Leads, Asia-Pacific Accelerates

• North America took the forefront in the glycomics or glycobiology market in 2022, dominating the market share.
• The spotlight is shifting towards Asia-Pacific, expected to be the fastest-growing region in the forecast period, driven by increased healthcare awareness, rising investments, and evolving healthcare infrastructures.

View More On The Glycomics or Glycobiology Market Report 2023 – https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Request A Sample Of The Global Glycomics or Glycobiology Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8749&type=smp

The Glycomics or Glycobiology Global Market Report 2023  provides a comprehensive overview on the glycomics or glycobiology market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Medical Equipment Global Market Report 2023
Medical And Diagnostic Laboratory Services Global Market Report 2023
Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model